Szmigielski A
Arch Int Pharmacodyn Ther. 1981 Jan;249(1):64-71.
The rat heart contains a large amount of two protein kinase inhibitors. The type I inhibitor blocks the activity of cAMP-dependent protein kinase while the type II inhibitor blocks cGMP-dependent protein kinase, cAMP-dependent protein kinase and cyclic nucleotide-independent protein kinase. Isoproterenol produced a dose-dependent decrease of the type I inhibitor activity and an increase of cAMP content in rat heart. The decrease of the type I inhibitor activity is mediated through adrenergic beta receptor because propranolol and practolol but not phentolamine prevented the effects of isoproterenol. Moreover, prior treatment with aminophylline markedly enhanced isoproterenol-induced increase of cAMP content and decrease of the type I inhibitor activity. Isoproterenol did not change the activity of the type II inhibitor. These results are compatible with the hypothesis that the neurotransmitter generated cAMP modulates phosphorylation in the heart by changing the relationship between cAMP-dependent protein kinase and the type I inhibitor activity.
大鼠心脏含有大量的两种蛋白激酶抑制剂。I型抑制剂可阻断cAMP依赖性蛋白激酶的活性,而II型抑制剂可阻断cGMP依赖性蛋白激酶、cAMP依赖性蛋白激酶和非环核苷酸依赖性蛋白激酶的活性。异丙肾上腺素使大鼠心脏中I型抑制剂活性呈剂量依赖性降低,cAMP含量增加。I型抑制剂活性的降低是通过肾上腺素β受体介导的,因为普萘洛尔和普拉洛尔而非酚妥拉明可阻止异丙肾上腺素的作用。此外,氨茶碱预先处理可显著增强异丙肾上腺素诱导的cAMP含量增加和I型抑制剂活性降低。异丙肾上腺素并未改变II型抑制剂的活性。这些结果与以下假设相符,即神经递质产生的cAMP通过改变cAMP依赖性蛋白激酶与I型抑制剂活性之间的关系来调节心脏中的磷酸化作用。